EUVIMEDEUVIMED entdecken
Crossref

Design, Synthesis and Biological Evaluation of Potent Piperazine-Based BioA Inhibitors Targeting Biotin Biosynthesis in Mycobacterium tuberculosis

Qiang Liu iD, Curtis A Engelhart, Joshua B Wallach, Peng Ge, Tsung-Yun Wong iD, Moyosore O Orimoloye iD, Suyapa Rodriguez, Yahani P Jayasinghe iD, Donald R Ronning iD, Véronique Dartois iD, Jansy P Sarathy iD, Dirk Schnappinger iD und 2 weitere

Journal of Medicinal Chemistry · 14.05.2026 · 69 (9) · 10315-10337

DOI: 10.1021/acs.jmedchem.5c03325 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 22.04.2026. Verfasst von Qiang Liu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, University of Minnesota, 308 Harvard Street SE, Minneapolis, Minnesota 55455, United States. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Drug Design, Biotin, Antitubercular Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: National Cancer Institute, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisDrug DesignBiotinAntitubercular AgentsBacterial ProteinsPiperazinesPiperazineMicrobial Sensitivity TestsStructure-Activity RelationshipHumansAnimalsTransaminases

Substanzen

BiotinAntitubercular AgentsBacterial ProteinsBioA protein, bacteriaPiperazinesPiperazineTransaminases

Autor:innen und Institutionen

  • Department of Medicinal Chemistry, University of Minnesota, 308 Harvard Street SE, Minneapolis, Minnesota 55455, United States.
  • Department of Microbiology and Immunology, Weill Cornell Medical College, 1300 York Avenue, New York, New York 10021, United States.
  • Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey 07110, United States.
  • Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska 68198, United States.

ORCID-Profile: Qiang Liu, Tsung-Yun Wong, Moyosore O Orimoloye, Yahani P Jayasinghe, Donald R Ronning, Véronique Dartois, Jansy P Sarathy, Dirk Schnappinger, Courtney C Aldrich

Förderung

  • National Cancer Institute
  • National Institutes of Health

Zitieren

APA

Liu, Q., Engelhart, C. A., Wallach, J. B., Ge, P., Wong, T. Y., Orimoloye, M. O., Rodriguez, S., Jayasinghe, Y. P., Ronning, D. R., Dartois, V., Sarathy, J. P., Schnappinger, D., Zimmerman, M. D., & Aldrich, C. C. (2026). Design, Synthesis and Biological Evaluation of Potent Piperazine-Based BioA Inhibitors Targeting Biotin Biosynthesis in Mycobacterium tuberculosis. Journal of Medicinal Chemistry, 69(9), 10315-10337. https://doi.org/10.1021/acs.jmedchem.5c03325

Vancouver

Liu Q, Engelhart CA, Wallach JB, Ge P, Wong TY, Orimoloye MO, et al. Design, Synthesis and Biological Evaluation of Potent Piperazine-Based BioA Inhibitors Targeting Biotin Biosynthesis in Mycobacterium tuberculosis. Journal of Medicinal Chemistry. 2026;69(9):10315-10337. doi:10.1021/acs.jmedchem.5c03325

BibTeX
@article{Liu2026,
  author = {Liu, Qiang and Engelhart, Curtis A and Wallach, Joshua B and Ge, Peng and Wong, Tsung-Yun and Orimoloye, Moyosore O and Rodriguez, Suyapa and Jayasinghe, Yahani P and Ronning, Donald R and Dartois, Véronique and Sarathy, Jansy P and Schnappinger, Dirk and Zimmerman, Matthew D and Aldrich, Courtney C},
  title = {Design, Synthesis and Biological Evaluation of Potent Piperazine-Based BioA Inhibitors Targeting Biotin Biosynthesis in Mycobacterium tuberculosis},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  volume = {69},
  number = {9},
  pages = {10315--10337},
  doi = {10.1021/acs.jmedchem.5c03325}
}
Kostenlos starten →